To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.

This bill expands Medicaid programs' requirement to monitor antipsychotic medication use to cover all Medicaid beneficiaries, not just children. It removes age restrictions by adding seniors (65+), individuals receiving home and community-based services, and those in institutional care (like nursing homes) to the monitoring scope, effective January 1, 2024. States will now need to track antipsychotic use for these new groups under existing Medicaid rules. The change directly affects all Medicaid enrollees, including previously excluded adults and seniors.